期刊文献+

一级子宫内膜样腺癌累及腺肌病临床病理分析 被引量:1

下载PDF
导出
摘要 目的探讨子宫内膜一级子宫内膜样腺癌(endometri-oid adenocarcinoma,EA)累及腺肌病(adenomyosis,AM)的临床病理特点及鉴别诊断。方法观察2例子宫内膜一级EA累及AM的临床病理和免疫组织化学特点,并复习相关文献。结果 2例患者均为中年妇女,年龄分别为47、52岁,表现为进行性痛经伴月经量增多和经期延长,彩色超声示子宫内膜增厚、子宫增大伴肌壁间不均匀回声。病理检查:大体观察子宫增大,子宫壁增厚,子宫体底部子宫内膜局限型结节状和息肉状肿块。镜下为子宫内膜无肌层侵犯的一级EA,肌层内受癌累及AM腺体与子宫内膜EA形态一致,呈膨胀式扩张推挤周围平滑肌,肿瘤周边可见子宫内膜间质细胞;同时肌层内见未被癌累及的腺体和间质细胞。免疫组化:受癌累及的AM腺体周围及肿瘤周边子宫内膜间质细胞CD10(+),desmin(-)。结论一级EA累及AM确诊主要依靠组织学和免疫组化,病理诊断容易误诊为EA肌层侵犯或AM恶变,应引起注意。
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2010年第5期622-624,共3页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献14

  • 1Kairi-Vassilatou E,Kontogianni K,Salamalekis M,et al.A clinic pathological study of the relationship between adenomyosis and other hormone-dependent uterine leison[J].Eur J Gyencol Oncol,2004,25(2):222-4.
  • 2余晓茹,郑飞云,杨孝军.子宫内膜癌合并子宫内膜异位症或子宫肌瘤的临床分析[J].武汉大学学报(医学版),2008,29(6):816-818. 被引量:6
  • 3高宝辉,谢丽微,祁旦巳,赵志光.子宫内膜样腺癌组织中p53蛋白和VEGF的表达及意义[J].临床与实验病理学杂志,2005,21(2):240-241. 被引量:7
  • 4贾学玲,高云荷,张煦.子宫内膜增生及内膜癌中PTEN、Ki-67蛋白的表达[J].临床与实验病理学杂志,2003,19(2):152-155. 被引量:19
  • 5SrodonM,KleinW M,KurmanR J.CD10 imunnostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis[J].Am J Surg Pathol,2003,27(6):786-9.
  • 6Nascimento A F,Hirsch M S,Cviko A,et al.The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis[J].Mod Pathol,2003,16(1):22-7.
  • 7Stephen S,Sternberg.诊断外科病理学[M] //回允中,译.第3版.北京:北京大学医学出版社,2003:2236-7.
  • 8Achaimers J.子宫内膜异位症专著[M] //赵允,译.上海:上海科学出版社,1986:105.
  • 9刘晨,赵彦.子宫腺肌症恶变1例及分析[J].中国妇产科临床杂志,2003,4(4):305-306. 被引量:6
  • 10Rubod C,Narducci F,Delattre C,et al.Endometrioid adenocarcinoma arising from adenomyosis.Acase report and literature review[J].J Gynecol Obstet Biol Reprod(Paris),2004,33(2):140-4.

二级参考文献28

  • 1熊光武,张国楠.子宫腺肌病恶变[J].实用妇产科杂志,2006,22(1):4-6. 被引量:5
  • 2Kairi-Vassilatou E, Kontogianni K, Salamalekis M ,et al. A clinic pathological study of the relationship between Adenomyosis and other hormone-dependent uterine lesion[J]. Eur J Gynecol Oncol, 2004, 25 (2):222- 224,
  • 3Nezhat F, Cohen C, Rahaman J, et al. Comparative immunohistochemical studies of bcl-2 and p53 potions in benign and malignant ovarian endometriosis cysts [J]. Cancer, 2002,94(11):2935-2936.
  • 4Clement PB, Young RH. Endometrioid Carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects[J]. Adv Anat Pathol,2002, 9(3):145-187.
  • 5Gehring V, Olaliye B. Estrogen receptor status determined by immunohistochemistry as predictor of the recurrence of state Ⅰ endometrial carcinoma[J]. Cancer, 1999, 8(6):2083-2089.
  • 6[1]Sampson JA.Endometrial carcioma of the ovary arising in endometrial tissue in that organ.ArchSurg,1925,10:1-12.
  • 7[2]王叔贞,袁耀,苏应宽,等.实用妇产科学.北京:人民卫生出版社,1987.759.
  • 8[6]Hayata T,Matsu T,Kawano Y,et al.Scanning electron microscopy of endometriotic lesions in the pelvic peritoneum and the histogenesis of endometriosis.Int J Gynecol Obstet,1992,39:311-319.
  • 9[7]Gucer F,Pieber D,Arikan MG.Malignancy arising in extraovarian endometriosis during estrogen stimulation.Eur J Gynecol Oncol,1998,19:39-41.
  • 10[8]Bohkman JK.Two pathogenetic types of endometrial carcinom.Gynecol Oncol,1983,15:10-17.

共引文献34

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部